Omicsveu is committed in advancing the pace of scientific research in order to improve cancer survival rates and quality of life for patients. We design, develop, and commercialize state-of-the-art, fully automated systems for all your spatial multiplex multiomics needs through our five main technologies: In Situ Sequencing Immunoplex, miRFISH, eFISH, Genotyping & Phenotyping